Clinical burden and implications of coronary interventions for in-stent restenosis

EuroIntervention 2021;17:355-357. DOI: 10.4244/EIJV17I5A60

Fernando Alfonso
Fernando Alfonso1, MD; Adnan Kastrati2, MD
1. Department of Cardiology, Hospital Universitario de La Princesa, IIS-IP, CIBER-CV, Madrid, Spain; 2. Deutsches Herzzentrum München, Technische Universität München, Munich, and DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
The impressive strides made by interventional cardiology in the last two decades have been able to improve the quality of life and the prognosis of patients with coronary artery disease. Novel drug-eluting stents (DES) and refined adjunct pharmacological therapies have provided unprecedented results in terms of the safety and efficacy of coronary revascularisation1. Notwithstanding these remarkable advances, stent failure still overshadows the results of percutaneous coronary interventions (PCI)2. Angiographic restenosis is still seen in routine clinical practice but tends to be considered a technical nuisance that, when clinically indicated, can be readily tackled by repeat interventions1,2. These reinterventions are simple ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
A step forward: imaging-based approach to in-stent restenosis

Latest news